Dr Reddy's Laboratories

Dr Reddy’s Lab board approves bonus debentures valued at Rs30/share

01 Apr 2010

Dr Reddy’ Labs posts consolidated net loss of Rs522 crore

21 Jan 2010

GSK inching closer to deal with Dr Reddy's?

08 Jan 2010

Dr Reddy’s all-new diabetes drug shows good results

06 Jan 2010

Dr Reddy's to launch new drugs to boost domestic operations

28 Dec 2009

Eli Lilly wins drug patent case vs Dr Reddy's in UK

18 Dec 2009

Dr Reddy's seeks US marketing rights for `Lipitor' generic

07 Nov 2009

Dr Reddy's July-September net zooms 106 per cent to Rs217 crore

23 Oct 2009

Glaxo seeking stake in Dr Reddy’s: report

18 Sep 2009

Dr Reddy's scotches stake sale rumours

11 Sep 2009

Dr Reddy's Lab launches skin patch pain reliever in India

06 Aug 2009

Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13

23 Jul 2009

Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore

21 Jul 2009

Glaxo ties up with Dr Reddy's for emerging markets

15 Jun 2009

Natco, Dr Reddy’s tie up for cancer generics

16 Apr 2009

Dr Reddy’s pulling out of small global markets

21 Mar 2009

Dr Reddy’s sales in Russia and CIS top $150 million

19 Mar 2009

US court clears Dr Reddy’s in Omeprazole Mg OTC litigation

13 Mar 2009

Dr Reddy's elevates Saumen Chakraborty as president, corporate and global generics, Umang Vohra as new CFO

02 Jan 2009

Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets

31 Jul 2008

Dr Reddy’s to buy back Perlecan Pharma stake from ICICI Ventures and Citigroup

22 Jul 2008

Dr. Reddy's in global Ibuprofen marketing pact with Albemarle

09 Jul 2008

Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy

03 Apr 2008

Dr Reddy's to buy two Dowpharma Small Molecules units in the UK

01 Apr 2008

Dr Reddy's Laboratories and 7TM Pharma sign drug research pact

10 Mar 2008